SE7714110L - Forfarande for framstellning av karboxylsyraderivat - Google Patents
Forfarande for framstellning av karboxylsyraderivatInfo
- Publication number
- SE7714110L SE7714110L SE7714110A SE7714110A SE7714110L SE 7714110 L SE7714110 L SE 7714110L SE 7714110 A SE7714110 A SE 7714110A SE 7714110 A SE7714110 A SE 7714110A SE 7714110 L SE7714110 L SE 7714110L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- carboxylic acid
- acid derivatives
- derivatives
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7637574A FR2374032A2 (fr) | 1976-12-14 | 1976-12-14 | Nouveaux acides carboxyliques derives de l'indane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7714110L true SE7714110L (sv) | 1978-06-15 |
| SE436740B SE436740B (sv) | 1985-01-21 |
Family
ID=9181028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7714110A SE436740B (sv) | 1976-12-14 | 1977-12-13 | Forfarande for framstellning av derivat av 5-bensoyl-indan-2-karboxylsyra eller salter eller alkylestrar derav |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5373548A (sv) |
| AT (1) | AT355559B (sv) |
| AU (1) | AU515268B2 (sv) |
| BE (1) | BE861826R (sv) |
| CA (1) | CA1088554A (sv) |
| CH (1) | CH627728A5 (sv) |
| DD (1) | DD133323A6 (sv) |
| DE (1) | DE2753315A1 (sv) |
| DK (1) | DK144640C (sv) |
| ES (1) | ES465056A2 (sv) |
| FR (1) | FR2374032A2 (sv) |
| GB (1) | GB1584298A (sv) |
| HU (1) | HU177226B (sv) |
| IE (1) | IE46013B1 (sv) |
| IL (2) | IL60598A0 (sv) |
| MX (1) | MX4954E (sv) |
| NL (1) | NL7713876A (sv) |
| NO (1) | NO774285L (sv) |
| SE (1) | SE436740B (sv) |
| SU (1) | SU799646A3 (sv) |
| ZA (1) | ZA777438B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2582674B1 (en) * | 2010-06-16 | 2014-10-01 | Cymabay Therapeutics, Inc. | Gpr120 receptor agonists and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4980053A (sv) * | 1972-12-05 | 1974-08-02 | ||
| JPS5838416B2 (ja) * | 1974-05-31 | 1983-08-23 | 武田薬品工業株式会社 | カンジヨウカゴウブツノセイゾウホウ |
| JPS5335944B2 (sv) * | 1974-05-21 | 1978-09-29 |
-
1976
- 1976-12-14 FR FR7637574A patent/FR2374032A2/fr active Granted
-
1977
- 1977-11-30 DE DE19772753315 patent/DE2753315A1/de not_active Ceased
- 1977-12-12 GB GB51699/77A patent/GB1584298A/en not_active Expired
- 1977-12-13 IE IE2520/77A patent/IE46013B1/en unknown
- 1977-12-13 DD DD7700202588A patent/DD133323A6/xx unknown
- 1977-12-13 HU HU77LI316A patent/HU177226B/hu unknown
- 1977-12-13 MX MX776686U patent/MX4954E/es unknown
- 1977-12-13 SE SE7714110A patent/SE436740B/sv unknown
- 1977-12-13 NO NO774285A patent/NO774285L/no unknown
- 1977-12-13 DK DK554677A patent/DK144640C/da not_active IP Right Cessation
- 1977-12-14 ZA ZA00777438A patent/ZA777438B/xx unknown
- 1977-12-14 CA CA293,076A patent/CA1088554A/fr not_active Expired
- 1977-12-14 JP JP14943377A patent/JPS5373548A/ja active Pending
- 1977-12-14 AU AU31530/77A patent/AU515268B2/en not_active Expired
- 1977-12-14 AT AT892577A patent/AT355559B/de not_active IP Right Cessation
- 1977-12-14 BE BE183429A patent/BE861826R/xx not_active IP Right Cessation
- 1977-12-14 NL NL7713876A patent/NL7713876A/xx not_active Application Discontinuation
- 1977-12-14 CH CH1541077A patent/CH627728A5/fr not_active IP Right Cessation
- 1977-12-14 ES ES465056A patent/ES465056A2/es not_active Expired
-
1979
- 1979-04-06 SU SU792746906A patent/SU799646A3/ru active
-
1980
- 1980-07-15 IL IL60598A patent/IL60598A0/xx unknown
- 1980-07-15 IL IL60599A patent/IL60599A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE46013B1 (en) | 1983-01-26 |
| NL7713876A (nl) | 1978-06-16 |
| SU799646A3 (ru) | 1981-01-23 |
| JPS5373548A (en) | 1978-06-30 |
| CH627728A5 (en) | 1982-01-29 |
| ES465056A2 (es) | 1979-01-16 |
| AU515268B2 (en) | 1981-03-26 |
| CA1088554A (fr) | 1980-10-28 |
| DK144640B (da) | 1982-04-26 |
| DK144640C (da) | 1982-10-04 |
| DD133323A6 (de) | 1978-12-27 |
| SE436740B (sv) | 1985-01-21 |
| NO774285L (no) | 1978-06-15 |
| AU3153077A (en) | 1979-06-21 |
| ATA892577A (de) | 1979-08-15 |
| DE2753315A1 (de) | 1978-06-15 |
| MX4954E (es) | 1983-01-13 |
| FR2374032A2 (fr) | 1978-07-13 |
| BE861826R (fr) | 1978-06-14 |
| HU177226B (en) | 1981-08-28 |
| ZA777438B (en) | 1979-05-30 |
| DK554677A (da) | 1978-06-15 |
| IL60598A0 (en) | 1980-09-16 |
| FR2374032B2 (sv) | 1979-03-30 |
| GB1584298A (en) | 1981-02-11 |
| IL60599A0 (en) | 1980-09-16 |
| IE46013L (en) | 1978-06-14 |
| AT355559B (de) | 1980-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR19755A (tr) | Tereftalik asidin hazirlanmasina mahsus usul | |
| SE429961B (sv) | Forfarande for framstellning av mjolksyra | |
| NO771578L (no) | Fremgangsmaate for fremstilling av di-n-propyleddiksyre | |
| SE7613565L (sv) | Forfarande for framstellning av fusidinsyraderivat | |
| SE7803853L (sv) | Forfarande for framstellning av estrar av oxalsyra | |
| NO821848L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| SE440080B (sv) | Forfarande for framstellning av klavulansyraderivat | |
| NO771263L (no) | Fremgangsm}te for fremstilling av indol-naftyridin-derivater | |
| SE421787B (sv) | Forfarande for framstellning av kvadratsyra | |
| NO773622L (no) | Fremgangsmaate til fremstilling av tereftalsyre | |
| NO152451C (no) | Fremgangsmaate for fremstilling av fosfonsyrederivater | |
| SE7601151L (sv) | Forfarande for framstellning av cefemkarboxylsyror | |
| SE436744B (sv) | Forfarande for framstellning av prostacyklinderivat | |
| SE7607322L (sv) | Forfarande for framstellning av 16-etrar av fusidinsyraderivat | |
| NO141716C (no) | Fremgangsmaate for fremstilling av tiokarbaminsyreestere | |
| SE7702922L (sv) | Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider | |
| SE7607026L (sv) | Forfarande for framstellning av 5-alkylpikolinsyra | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE7604940L (sv) | Forfarande for framstellning av sulfamylbensoesyror | |
| SE7714110L (sv) | Forfarande for framstellning av karboxylsyraderivat | |
| SE427037B (sv) | Forfarande for framstellning av deoxiklavulansyra | |
| DK9477A (da) | Fremgangsmade til fremstilling af karboxylsyrederivater af indan | |
| SE7714765L (sv) | Forfarande for framstellning av omega-aryl-13-prostyn-syraderivat | |
| SE7706725L (sv) | Forfarande for framstellning av cefemderivat |